IMPACT THERAP-B
0763018AListed醫療健康 · IMPACT Therapeutics是一家专注于肿瘤靶向疗法研发的中国生物制药公司。
High attention
80.2
/100
- Offer price
- HK$20.10
- Final offer price
- HK$20.10
- Lot / entry fee
- 200 shares · HK$4K
- Proceeds
- HK$843.7M
- Sponsor
- Goldman Sachs / CICC
- Est. margin oversub.
- 1388.0x
- Public oversub.
- 2282.4x
- One-lot win rate
- 1.5%
- First-day return
- +108.3%
Offer starts
May 5
Offer closes
May 8
Grey market
May 12
Listing
May 13
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
80.2/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Strong positivePartial basis
Up probability
97.2%
First-day reference range
+50.7% – +134.8%
Published outcome check
First-day resultBig up+108.3%
Our call: Trend call valid
Covered 22/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
Average supportPost-lockup offer value
Medium scarcityRecent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Average qualityGrowth quality
Average qualityProfitability
Weak qualityCash runway
High qualityCustomer concentration
High riskCornerstone quality
Strong supportSponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track recordGoldman Sachs
Weak recordA-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe useCumulative use 0.0%
Good supportGrey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.